Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Optimizing CML Management: Shared Decision Making and Enhancing the Patient Experience : Episode 2

      Navigating CML: Tools to Empower Patients and Caregivers

      July 31, 2024
      By Jorge E. Cortes, MD
      Joannie Clements
      • Claire Saxton

      Opinion
      Video

      Joannie Clements, a patient advocate, provides insights on helping newly diagnosed patients with CML and their caregivers navigate the complexities of diagnosis, and Claire Saxton outlines resources available for them.

      EP: 1.Understanding CML: Your Journey from Diagnosis to Treatment

      Now Viewing

      EP: 2.Navigating CML: Tools to Empower Patients and Caregivers

      EP: 3.Empowering CML Caregivers: Strategies and Support Systems

      EP: 4.Starting CML Treatment: Collaborative Choices for Better Outcomes

      EP: 5.Open Dialogue in CML Care: Setting Expectations, Managing Side Effects, and Optimizing Patient Quality of Life

      EP: 6.When CML Therapy Shifts: Collaborative Approaches to Treatment Changes

      EP: 7.CML Treatment: Scenarios that Necessitate Switching Therapy

      EP: 8.Ensuring Informed CML Care from Diagnosis Onward

      EP: 9.Advancing CML Management Towards an Ideal Patient Journey

      This program was made possible with support from Novartis Pharmaceuticals.

      Video content above is prompted by the following questions:

      • As a patient advocate, how do you help newly diagnosed CML patients and their caregivers navigate the complexities of the diagnosis and set appropriate care goals? What are some of the biggest challenges patients may face at this stage?
      • What resources or educational materials have you found most helpful in supporting newly diagnosed CML patients and their caregivers?
        • How do patients typically use these materials? How have you changed your approaches so patients and caregivers can best leverage these materials?

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Photo of a man wearing a suit in front of an Oncology Nursing News backdrop
      Headshot of a woman with black hair wearing a pearl necklace and a white blouse
      Image of a woman with wavy brown hair in front of a blue background
      Related Content

      Image of blood cancer cells

      Subcutaneous Daratumumab Reduces Smoldering Myeloma Progression

      Russ Conroy
      September 12th 2025
      Article

      The Vitals

      Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

      Lindsay Fischer
      September 12th 2025
      Podcast

      Image of bone marrow with cancer cells

      Venetoclax Combo Did Not Increase OS in Intermediate/High-Risk MDS

      Ariana Pelosci
      September 12th 2025
      Article

      Laura Zitella Discusses the Growing Arsenal of Bispecific Antibodies in DLBCL

      Laura Zitella Discusses the Growing Arsenal of Bispecific Antibodies in DLBCL

      Lindsay Fischer
      September 12th 2025
      Podcast

      Photo of a woman with blond hair wearing a white and black blazer

      How to Manage ICANS in Patients With Hematologic Cancers

      Gina Mauro
      September 12th 2025
      Article

      Photo of a woman with blonde hair wearing a white and black blazer

      Managing CRS in Hematologic Cancers: A Nursing Perspective

      Gina Mauro
      September 12th 2025
      Article
      Related Content

      Image of blood cancer cells

      Subcutaneous Daratumumab Reduces Smoldering Myeloma Progression

      Russ Conroy
      September 12th 2025
      Article

      The Vitals

      Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

      Lindsay Fischer
      September 12th 2025
      Podcast

      Image of bone marrow with cancer cells

      Venetoclax Combo Did Not Increase OS in Intermediate/High-Risk MDS

      Ariana Pelosci
      September 12th 2025
      Article

      Laura Zitella Discusses the Growing Arsenal of Bispecific Antibodies in DLBCL

      Laura Zitella Discusses the Growing Arsenal of Bispecific Antibodies in DLBCL

      Lindsay Fischer
      September 12th 2025
      Podcast

      Photo of a woman with blond hair wearing a white and black blazer

      How to Manage ICANS in Patients With Hematologic Cancers

      Gina Mauro
      September 12th 2025
      Article

      Photo of a woman with blonde hair wearing a white and black blazer

      Managing CRS in Hematologic Cancers: A Nursing Perspective

      Gina Mauro
      September 12th 2025
      Article

      Latest Conference Coverage

      Safety Management With Amivantamab Plus Lazertinib in NSCLC

      Tepotinib Shows Manageable Safety in MET Exon 14+ NSCLC

      Adverse Events of Menin Inhibitors in AML: What Nurses Should Know

      Ivonescimab/Chemo Ups PFS After Third-Generation TKI in EGFR+ NSCLC

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      259 Prospect Plains Rd, Bldg H,
      Monroe, NJ 08831

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.